-
1Academic Journal
المؤلفون: Sally Hollis, Christine Fletcher, Frances Lynn, Hans-Joerg Urban, Janice Branson, Hans-Ulrich Burger, Catrin Tudur Smith, Matthew R. Sydes, Christoph Gerlinger
المصدر: BMC Medical Research Methodology, Vol 16, Iss S1, Pp 15-22 (2016)
مصطلحات موضوعية: Medicine (General), R5-920
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Nick Manamley, Steve Mallett, Matthew R. Sydes, Sally Hollis, Alison Scrimgeour, Hans Ulrich Burger, Hans-Joerg Urban
المصدر: BMC Medical Research Methodology, Vol 16, Iss S1, Pp 37-43 (2016)
مصطلحات موضوعية: Statistician, Clinical trial, Data sharing, Transparency, Pharmaceutical research, Biotechnology research, Medicine (General), R5-920
وصف الملف: electronic resource
-
3
المؤلفون: Gaetano Finocchiaro, Rodica Anghel, Hans Joerg Urban, George Fountzilas, Warren Mason, Martina Makrutzki, O. L. Chinot, Dana Cernea, François Ghiringhelli, Alba A. Brandes, Miguel Gil-Gil, Enrico Franceschi, Giuseppe Lombardi, Patrick Beauchesne, Chiedzo Mpofu, Josef Pichler, Antoine F. Carpentier, François Dubois, Vittorina Zagonel, Frank Saran, Anna K. Nowak
المساهمون: Department of Medical Oncology (AUSL di Bologna), Azienda Unità Sanitaria Locale di Bologna (AUSL), Institut Català d' Oncologia, IDIBELL, Royal Marsden NHS Foundation Trust, Université Paris Diderot - Paris 7 (UPD7), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), School of medecine (University of Western Australia), The University of Western Australia (UWA), Cancer Clinical Research Unit (CCRU), University of Toronto, Princess Margaret Cancer Centre, Veneto Institute of Oncology IOV-IRCCS [Padua, Italy], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Aristotle University of Thessaloniki, The Oncology Institute 'Prof. Dr. Ion Chiricuta', Assistance Publique - Hôpitaux de Marseille (APHM), Institute of Oncology Prof. Dr. Alexandru Trestioreanu (IOB), University of Medicine and Pharmacy 'Carol Davila' Bucharest (UMPCD), Département d'oncologie médicale [Centre Georges-François Leclerc], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER, Service de Neuro-Oncologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), F. Hoffmann-La Roche [Basel], Konsiliardienstes Innere Medizin mit Neuroonkologie, Johannes Kepler Universität
المصدر: Oncologist
Oncologist, AlphaMed Press, In press, pp.theoncologist.2018-0290. ⟨10.1634/theoncologist.2018-0290⟩مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Randomization, Bevacizumab, [SDV.CAN]Life Sciences [q-bio]/Cancer, Placebo, Continuous bevacizumab, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Double-Blind Method, Internal medicine, Multicenter trial, Clinical endpoint, Recurrent glioblastoma, Medicine, Humans, Overall survival, Neuro‐Oncology, Aged, Temozolomide, business.industry, Brain Neoplasms, Hazard ratio, Lomustine, Middle Aged, Prognosis, 3. Good health, Clinical trial, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Neoplasm Recurrence, Local, business, Glioblastoma, medicine.drug, Follow-Up Studies
-
4
المؤلفون: Antoine F. Carpentier, Olivier Chinot, Josef Pichler, Chiedzo Mpofu, Alba A. Brandes, Dana Cernea, Gaetano Finocchiaro, Miquel Gil Gil, Martina Makrutzki, Warren P. Mason, George Fountzilas, Hans-Joerg Urban, François Dubois, Frank Saran, Anna K. Nowak, Vittorina Zagonel
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Temozolomide, Bevacizumab, business.industry, medicine.medical_treatment, Phases of clinical research, Lomustine, Chemotherapy regimen, 030218 nuclear medicine & medical imaging, Radiation therapy, 03 medical and health sciences, Abstracts, 0302 clinical medicine, Internal medicine, medicine, Neurology (clinical), Progression-free survival, Adverse effect, business, medicine.drug